Profil
Matthew W.
Onaitis is currently Director at Snp Bio, Inc. and Stratify Genomics, Inc., and Chief Financial Officer at Mainstay Medical International Ltd. since 2018.
Formerly, Mr. Onaitis was Director-Legal Affairs at Elan Corp.
Plc (2004-2005), Associate General Counsel at Biogen, Inc. (2006), Secretary, Senior Vice President & General Counsel at Somaxon Pharmaceuticals, Inc. (2010-2013), Secretary & General Counsel at Trius Therapeutics, Inc. (2013), Secretary & General Counsel at Ignyta, Inc. (2014-2016), and CFO, Secretary, CAO & General Counsel at Cidara Therapeutics, Inc. (2016-2018).
Education includes an undergraduate degree from Carnegie Mellon University (1993) and a graduate degree from Stanford Law School (1998).
Postes actifs de Matthew Onaitis
| Sociétés | Poste | Début |
|---|---|---|
| MAINSTAY MEDICAL INTERNATIONAL | Directeur Financier/CFO | 20/08/2018 |
Snp Bio, Inc. | Directeur/Membre du Conseil | - |
Stratify Genomics, Inc.
Stratify Genomics, Inc. Medical/Nursing ServicesHealth Services Operates as a cancer risk stratification company | Directeur/Membre du Conseil | - |
Anciens postes connus de Matthew Onaitis
| Sociétés | Poste | Fin |
|---|---|---|
| CIDARA THERAPEUTICS | Directeur Financier/CFO | 17/08/2018 |
| IGNYTA INC | Conseiller Juridique Général | 01/06/2016 |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Conseiller Juridique Général | 01/12/2013 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Conseiller Juridique Général | 01/03/2013 |
| BIOGEN INC. | Corporate Officer/Principal | 01/05/2006 |
Formation de Matthew Onaitis
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Carnegie Mellon University
Carnegie Mellon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Mainstay Medical International Ltd.
Mainstay Medical International Ltd. Medical SpecialtiesHealth Technology Develops neurostimulation therapies for people with chronic mechanical low back pain | Health Technology |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Health Technology |
Ignyta, Inc.
Ignyta, Inc. BiotechnologyHealth Technology Operates as a medicine biotechnology company which provides new drugs services for cancer patients | Health Technology |
Stanford Law School
Stanford Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cidara Therapeutics, Inc.
Cidara Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in the discovery, development, and commercialization of novel anti-infectives | Health Technology |
Snp Bio, Inc. | |
Stratify Genomics, Inc.
Stratify Genomics, Inc. Medical/Nursing ServicesHealth Services Operates as a cancer risk stratification company | Health Services |
















